Benitec Biopharma (BJ9) Q2 2026 Earnings Report
DE:BJ9 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.23
- Consensus EPS
- -EUR 0.20
- Beat/Miss
- Missed by -EUR 0.03
- One Year Ago EPS
- -EUR 0.30
DE:BJ9 Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 02/12/2026
- Time
- Before Open
- Conference Call
- Thursday, February 12, 2026
DE:BJ9 Upcoming Earnings
Benitec Biopharma's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BJ9 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2027 (Q1) | -0.25- | -0.2 | ― | ― |
| Sep 14, 2026 | 2026 (Q4) | -0.24-0.23 | -0.36 | 35.80% (+0.13) | |
| May 14, 2026 | 2026 (Q3) | -0.24-0.21 | -0.21 | 0.00% (+0.00) | |
| Feb 12, 2026 | 2026 (Q2) | -0.20-0.23 | -0.3 | 21.21% (+0.06) | |
| Nov 14, 2025 | 2026 (Q1) | -0.40-0.20 | -0.43 | 54.17% (+0.23) | |
| Sep 22, 2025 | 2025 (Q4) | -0.28-0.36 | 0.93 | -138.94% (-1.29) | |
| May 14, 2025 | 2025 (Q3) | -0.31-0.21 | -1.47 | 85.37% (+1.25) | |
| Feb 14, 2025 | 2025 (Q2) | -0.69-0.30 | -2.36 | 87.50% (+2.07) | |
| Nov 14, 2024 | 2025 (Q1) | -0.49-0.43 | -2.47 | 82.61% (+2.04) | |
| Sep 26, 2024 | 2024 (Q4) | -0.440.93 | -0.01 | 10500.00% (+0.94) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
